Racial disparities in staging, treatment, and mortality in non-small cell lung cancer
Translational Lung Cancer Research · 2024-01 · 13 (1) · 76-94
DOI: 10.21037/tlcr-23-407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2024-01. Verfasst von Francesca C Duncan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Black race is associated with advanced stage at diagnosis and increased mortality in non-small cell lung cancer (NSCLC). Most studies focus on race alone, without accounting for social determinants of health (SDOH). We explored the hypothesis that racial disparities in stage at diagnosis and outcomes are associated with SDOH and influence treatment decisions by patients and providers.
Methods
Patients with NSCLC newly diagnosed at Indiana University Simon Comprehensive Cancer Center (IUSCCC) from January 1, 2000 to May 31, 2015 were studied. Multivariable regression analyses were conducted to examine the impact of SDOH (race, gender, insurance status, and marital status) on diagnosis stage, time to treatment, receipt of and reasons for not receiving guideline concordant treatment, and 5-year overall survival (OS) based on Kaplan-Meier curves.
Results
A total of 3,349 subjects were included in the study, 12.2% of Black race. Those diagnosed with advanced-stage NSCLC had a significantly higher odds of being male, uninsured, and Black. Five-year OS was lower in those of Black race, male, single, uninsured, Medicare/Medicaid insurance, and advanced stage. Adjusted for multiple variables, individuals with Medicare, Medicare/Medicaid, uninsured, widowed, and advanced stage at diagnosis, were associated with significantly lower OS time. Black, single, widowed, and uninsured individuals were less likely to receive stage appropriate treatment for advanced disease. Those uninsured [odds ratio (OR): 3.876, P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
- Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA.
- Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA.
- Indiana Clinical and Translational Science Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
- Department of Biostatistics and Epidemiology, Rutgers Cancer Institute of New Jersey, Rutgers School of Public Health, New Brunswick, NJ, USA.
- Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
Förderung
- BLRD VA
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Duncan, F. C., Al Nasrallah, N., Nephew, L., Han, Y., Killion, A., Liu, H., Al-Hader, A., & Sears, C. R. (2024). Racial disparities in staging, treatment, and mortality in non-small cell lung cancer. Translational Lung Cancer Research, 13(1), 76-94. https://doi.org/10.21037/tlcr-23-407
Vancouver
Duncan FC, Al Nasrallah N, Nephew L, Han Y, Killion A, Liu H, et al. Racial disparities in staging, treatment, and mortality in non-small cell lung cancer. Translational Lung Cancer Research. 2024;13(1):76-94. doi:10.21037/tlcr-23-407
BibTeX
@article{Duncan2024,
author = {Duncan, Francesca C and Al Nasrallah, Nawar and Nephew, Lauren and Han, Yan and Killion, Andrew and Liu, Hao and Al-Hader, Ahmad and Sears, Catherine R},
title = {Racial disparities in staging, treatment, and mortality in non-small cell lung cancer},
journal = {Translational Lung Cancer Research},
year = {2024},
volume = {13},
number = {1},
pages = {76--94},
doi = {10.21037/tlcr-23-407}
}
EUVIMED